Skip to main content

Table 1 Baseline characteristics of the study population according to survival and non-survival at 30-days

From: The prognostic value of red blood cell distribution width in patients with suspected infection in the emergency department

 

Total (n = 1046)

Non-survivors (n = 61)

Survivors (n = 985)

p-value

Gender (male) – no. (%)

563 (53.8)

37 (60.7)

526 (53.4)

0.270

Age – yr - median (IQR)

61.0 (50–72)

68.0 (61.5–78.0)

61.0 (46.0–69.0)

< 0.001

Comorbidities

 Hematologic malignancy – no. (%)

178(17.0)

10 (16.4)

168 (17.1)

0.960

 Chronic renal failure ≥ stage 3 – no. (%)

204(19.5)

13 (22.4)

191 (19.4)

0.713

 Immunocompromised – no. (%)

392 (37.5)

15 (24.6)

377 (38.3)

0.092

 Neutropenia due to systemic chemotherapy – no. (%)

45 (4.3)

1 (1.7)

44 (4.5)

0.999

CCI - median (IQR)

4.0 (2–7)

7.0 (5–9)

4.0 (2–6)

< 0.001

Vasopressor need – no. (%)

36 (3.4)

8 (13.1)

28 (2.8)

< 0.001

RDW (%) median (IQR)

13.42 (12.30–15.11)

14.74 (13.23–16.71)

13.38 (12.27–14.99)

< 0.001

Disease severity scores

 qSOFA ≥2 – no (%)

82 (7.8)

16 (26.2)

66 (6.7)

< 0.001

 SIRS score ≥ 2 – no (%)

656 (58.6)

46 (75.4)

610 (61.9)

0.035

 MEWS – median (IQR)

2 (1–4)

3 (1–5)

2 (1–4)

< 0.001

 Sepsis according to emergency physician – no. (%)

160 (15.3)

17 (27.9)

143 (14.5)

0.005

  1. No number, Yr year, IQR Interquartile range, CCI Charlson Comorbidity Index, qSOFA quick Sequential (Sepsis-related) Organ Failure Assessment, SIRS Systemic Inflammatory Response Syndrome, MEWS Modified Early Warning Score, RDW Red Blood cell Distribution Width